Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
about
A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopyMolecular probes for imaging of hypoxia in the retinaMultiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatment.Current issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia.Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervixExpression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix.Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.Delta-like ligand 4-notch blockade and tumor radiation response.Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.Oxygen Mapping of Melanoma Spheroids using Small Molecule Platinum Probe and Phosphorescence Lifetime Imaging Microscopy.Oxygen distribution in murine tumors: characterization using oxygen-dependent quenching of phosphorescence.Tumor hypoxia imaging.The Effects of Platelet-Activating Factor on Uterine Contractility, Perfusion, Hypoxia, and Pain in Mice.Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.Effect of distributional heterogeneity on the analysis of tumor hypoxia based on carbonic anhydrase IX
P2860
Q24646209-96168B9D-2A16-44E1-848F-F91711C6E86EQ34556234-EE159926-4CC7-4A10-AF90-F39AB59668AEQ34762148-F0C9D312-D558-44DE-A610-A8248C28595BQ35861042-8DB568AF-B54B-489C-AC9C-05B190AD0074Q36014483-E4E2170E-6CDA-42D5-9C92-A5AE26F469E1Q36298320-463E9AF6-C4B6-483C-930F-1BD7799C2366Q36613493-E27B3BCF-AB92-4584-8E8C-F629F0CADA23Q36617005-1258FA83-FB31-48FF-84CD-BAB959816A75Q36671784-A6544DBF-0FD8-4794-BE30-C948ABBFBB30Q38602274-AFF259E6-44DB-49D8-ACC4-A27E3B31FFFBQ39456092-B6B93B2F-518D-41BA-871F-4D95FC6D0F7BQ39592768-E1955124-E94B-410A-81E6-FA8453EE4B76Q41629472-0A5245CD-F98C-421E-91B4-0EE7A3E8773FQ45173457-13A12D3D-9A0D-4268-AABE-C97243D35FD7Q53272680-39DFE24E-BEEF-497B-8F0E-06F7658AC381Q53735908-776391F8-D064-4391-A03F-29261598C3C5Q54493753-3D162958-BE13-4EDF-BCD2-74C6367EE71FQ57617804-A0085CA7-740D-4126-A645-2BBB14A29F97
P2860
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
@ast
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
@en
type
label
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
@ast
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
@en
prefLabel
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
@ast
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
@en
P2093
P1476
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma
@en
P2093
H Havsteen
J A Raleigh
J C Lindegaard
J Loncaster
J Overgaard
M Nordsmark
P304
P356
10.1016/S0360-3016(00)01493-0
P407
P577
2001-02-01T00:00:00Z